Brazilian pharma leader across consumer health, prescription, generics, and dermocosmetics
Hypera is a diversified Brazilian pharmaceutical manufacturer with 5,000+ employees and a portfolio spanning over-the-counter consumer health (Benegrip, Buscopan, Engov), prescription drugs (Mantecorp), generics (Neo Química), and skincare brands. The company is SAP-heavy (FI, CO, SD, PI/PO, BTP) with modern analytics (Power BI, Kibana, Google Analytics 4) and is actively migrating trade and supply-chain operations—current projects center on SAP SD/DMP automation, marketplace infrastructure (Hympar B2B), and CRM systems for medical channels. Sales and marketing dominate the hiring mix, suggesting a push to expand beyond traditional pharmacy channels into hospitals and institutional care.
Hypera Pharma operates one of Brazil's largest and most diversified pharmaceutical portfolios. The company serves consumer health (OTC, vitamins, supplements), prescription markets, generic drugs, and dermocosmetics across retail and institutional channels (hospitals and clinics). Headquartered in São Paulo and publicly listed on the Novo Mercado since 2008, Hypera employs over 3,400 people. The organization has achieved ESG index inclusion and is actively scaling sales and marketing teams while modernizing its supply chain and CRM infrastructure to capture growth in institutional markets.
Hypera runs on SAP enterprise software (FI, CO, SD, BTP, Fiori, ABAP), SQL Server/SQL databases, Salesforce CRM, Power BI and Kibana for analytics, AWS and Azure cloud, and VTEX for e-commerce. IQVIA and Coupa are also in use for specialized pharma and procurement functions.
Current projects include SAP SD/DMP automation, Hympar B2B marketplace development, CRM implementation for medical channels, dashboard and KPI infrastructure, trade centralization, and seasonal/joint business plan campaigns focused on reducing stockouts and improving shelf share.
Other companies in the same industry, closest in size